title: Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study.
abstract: Disturbed glucose brain metabolism after brain trauma is reflected by changes in extracellular glucose levels. The authors hypothesized that posttraumatic reductions in extracellular glucose levels are not due to ischemia and are associated with poor outcome. Intracerebral microdialysis, electroencephalography, and measurements of brain tissue oxygen levels and jugular venous oxygen saturation were performed in 30 patients with traumatic brain injury. Levels of glucose, lactate, pyruvate, glutamate, and urea were analyzed hourly. The 6-month Glasgow Outcome Scale extended (GOSe6) score was assessed for each patient. In regions of increased glucose utilization defined by positron emission tomography, the extracellular glucose concentration was less than 0.2 mmol/l. Extracellular glucose values were less than 0.2 mmol during postinjury days 0 to 7 in 19% to 30% of hourly samples on each day. Transient decreases in glucose levels occurred with electrographic seizures and nonischemic reductions in cerebral perfusion pressure and jugular venous oxygen saturation. Glutamate levels were elevated in the majority of low-glucose samples, but the lactate/pyruvate ratio did not indicate focal ischemia. Terminal herniation resulted in reductions in glucose with increases in the lactate/pyruvate ratio but not in lactate concentration alone. GOSe6 scores correlated with persistently low glucose levels, combined early low glucose levels and low lactate/glucose ratio, and with the overall lactate/glucose ratio. These results suggest that the level of extracellular glucose is typically reduced after traumatic brain injury and associated with poor outcome, but is not associated with ischemia.
authors.affiliation: Division of Neurosurgery, David Geffen School of Medicine at University of California at Los Angeles, CA, USA. Pvespa@mednet.ucla.edu
authors.forename: Paul M
authors.initials: PM
authors.lastname: Vespa
authors.forename: David
authors.initials: D
authors.lastname: McArthur
authors.forename: Kristine
authors.initials: K
authors.lastname: O'Phelan
authors.forename: Thomas
authors.initials: T
authors.lastname: Glenn
authors.forename: Maria
authors.initials: M
authors.lastname: Etchepare
authors.forename: Daniel
authors.initials: D
authors.lastname: Kelly
authors.forename: Marvin
authors.initials: M
authors.lastname: Bergsneider
authors.forename: Neil A
authors.initials: NA
authors.lastname: Martin
authors.forename: David A
authors.initials: DA
authors.lastname: Hovda
mesh_terms: D000328:Adult; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D001930:Brain Injuries / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D005110:Extracellular Space / Q000737:chemistry*; D005260:Female; D015600:Glasgow Coma Scale; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D019344:Lactic Acid / Q000378:metabolism*; D008297:Male; D017551:Microdialysis; D008875:Middle Aged; D013223:Statistics as Topic; D016896:Treatment Outcome
chemical_list: D019344:Lactic Acid; D005947:Glucose